EGFR exon 19 deletion + EGFR L643V	Non Small Cell Lung Cancer	EGFR exon 19 deletion + EGFR L643V	Non Small Cell Lung Cancer	icotinib Resistant: D – Preclinical icotinib Resistant : D	icotinib Resistant: D – Preclinical icotinib Resistant : D
EGFR exon 19 deletion + EGFR L643V	Non Small Cell Lung Cancer	EGFR exon 19 deletion + EGFR L643V	Non Small Cell Lung Cancer	erlotinib Resistant: D – Preclinical erlotinib Resistant : D	erlotinib Resistant: D – Preclinical erlotinib Resistant : D
EGFR exon 19 deletion + EGFR L643V	Non Small Cell Lung Cancer	EGFR exon 19 deletion + EGFR L643V	Non Small Cell Lung Cancer	gefitinib Sensitive: D – Preclinical gefitinib Sensitive : D	gefitinib Sensitive: D – Preclinical gefitinib Sensitive : D
EGFR exon 19 deletion + EGFR L643V	Non Small Cell Lung Cancer	EGFR exon 19 deletion + EGFR L643V	Non Small Cell Lung Cancer	osimertinib Sensitive: D – Preclinical osimertinib Sensitive : D	osimertinib Sensitive: D – Preclinical osimertinib Sensitive : D

EGFR exon 19 deletion + EGFR L643V

Associations